Spots Global Cancer Trial Database for LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema

Official Title: Lymfo-Veneuse Anastomosen Ter Preventie Van Lymphoedeem

Study ID: NCT05601037

Conditions

Lymphedema, Breast Cancer

Interventions

Axilla dissection + Lymphovenous anastomosis

Study Description

Brief Summary: Lymphedema is defined as a chronic condition, caused by lymphostasis. A major part in the Western world consists of iatrogenic lymphedema caused by surgery to the lymph nodes of the axilla or groin. Prophylactic lymphovenous anastomosis (LVA) could be beneficial in the prevention of lymphedema of the extremities.

Detailed Description: The investigator is performing a blinded randomized prospective study on 80 patients undergoing an axilla dissection for their breast cancer treatment. One group will receive a LVA at the time of their axilla dissection. Other group will receive standard of care. Follow-up is 2 year.